ABCL
Price
$1.98
Change
-$0.11 (-5.26%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
593.98M
83 days until earnings call
IPSC
Price
$0.58
Change
-$0.02 (-3.33%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
51.7M
78 days until earnings call
Interact to see
Advertisement

ABCL vs IPSC

Header iconABCL vs IPSC Comparison
Open Charts ABCL vs IPSCBanner chart's image
AbCellera Biologics
Price$1.98
Change-$0.11 (-5.26%)
Volume$53.32K
Capitalization593.98M
Century Therapeutics
Price$0.58
Change-$0.02 (-3.33%)
Volume$11.16K
Capitalization51.7M
ABCL vs IPSC Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. IPSC commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and IPSC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (ABCL: $1.99 vs. IPSC: $0.58)
Brand notoriety: ABCL and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 55% vs. IPSC: 129%
Market capitalization -- ABCL: $593.98M vs. IPSC: $51.7M
ABCL [@Biotechnology] is valued at $593.98M. IPSC’s [@Biotechnology] market capitalization is $51.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 4 bearish.
  • IPSC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ABCL and IPSC are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а -2.93% price change this week, while IPSC (@Biotechnology) price change was +18.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($594M) has a higher market cap than IPSC($51.7M). ABCL YTD gains are higher at: -32.082 vs. IPSC (-42.614). IPSC has higher annual earnings (EBITDA): -117.21M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. IPSC (198M). IPSC has less debt than ABCL: IPSC (54.6M) vs ABCL (67.8M). ABCL has higher revenues than IPSC: ABCL (23.1M) vs IPSC (2.68M).
ABCLIPSCABCL / IPSC
Capitalization594M51.7M1,149%
EBITDA-211.2M-117.21M180%
Gain YTD-32.082-42.61475%
P/E RatioN/AN/A-
Revenue23.1M2.68M861%
Total Cash605M198M306%
Total Debt67.8M54.6M124%
TECHNICAL ANALYSIS
Technical Analysis
ABCLIPSC
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCANX11.90N/A
N/A
Fidelity Advisor Asset Manager 30% C
PLGJX9.97N/A
N/A
Principal LargeCap Growth I J
BEMIX9.67N/A
N/A
Brandes Emerging Markets Value I
LQFLX13.61N/A
N/A
Lord Abbett Focused Large Cap Value R3
BWLIX22.96-0.44
-1.88%
American Beacon Man Lg Cp Value Inv

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-4.78%
CRSP - ABCL
61%
Loosely correlated
-5.76%
ABSI - ABCL
59%
Loosely correlated
-3.23%
RXRX - ABCL
58%
Loosely correlated
-10.00%
NTLA - ABCL
57%
Loosely correlated
-4.86%
BEAM - ABCL
57%
Loosely correlated
-2.99%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-3.40%
CRSP - IPSC
55%
Loosely correlated
-5.76%
IMNM - IPSC
50%
Loosely correlated
-7.48%
NTLA - IPSC
49%
Loosely correlated
-4.86%
ABCL - IPSC
49%
Loosely correlated
-4.78%
BEAM - IPSC
47%
Loosely correlated
-2.99%
More